Profitability Metrics

Gross Margin
46.44%
Operating Margin
108.91%
Net Margin
95.75%

Efficiency Metrics

Revenue per Expense Ratio
1.00
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
108.91%
Income Tax Rate
0.00%
EPS
2.3800000000

Balance Sheet Analysis

Current Ratio
37.95
Cash Ratio
1.95
Working Capital
$409.43M
Debt to Equity
0.36
Debt to Assets
25.61%
Equity Ratio
71.34%

Cash Flow Analysis

Operating Cash Flow Ratio
52.94%
Free Cash Flow Ratio
52.94%
CapEx to Revenue
0.00%
Dividends Paid
$28.76M
Stock Buybacks
No buybacks
Total Shareholder Returns
$28.76M
Cash Position Change
106.90%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased dividend payments by 13.10%

Detailed Growth Metrics

Core Performance

Revenue
209.31%
Net Income
201.04%
EPS
201.28%
Operating Income
221.47%

Operational Efficiency

R&D Expenses
0.00%
SG&A Expenses
3.30%
Operating Cash Flow
-26.49%
Free Cash Flow
-26.49%

Balance Sheet Health

Assets
7.07%
Debt
0.92%
Book Value per Share
6.62%
Inventory
-100.00%

Shareholder Returns

Dividends per Share
13.10%
Shares Outstanding
0.00%

Long Term Trends

3Y Revenue/Share
1,183.05%
5Y Revenue/Share
440.11%
3Y Dividend/Share
-5.55%
5Y Dividend/Share
-20.08%